Skip to main content
logo
RemeGen Co., Ltd. (HKG:9995)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
115.20
+4.80 (4.35%)
Apr 2, 2026, 4:08 PM HKT

RemeGen Revenue

In the year 2025, RemeGen had annual revenue of 3.25B CNY with 89.36% growth. RemeGen had revenue of 1.53B in the quarter ending December 31, 2025, with 201.43% growth.

Revenue
3.25B CNY
Revenue Growth
+89.36%
P/S Ratio
23.28
Revenue / Employee
1.07M CNY
Employees
3,048
Market Cap
84.21B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.25B1.53B89.36%
Dec 31, 20241.72B633.91M58.54%
Dec 31, 20231.08B310.84M40.26%
Dec 31, 2022772.11M-651.79M-45.78%
Dec 31, 20211.42B--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sino Biopharmaceutical35.43B
WuXi Biologics24.25B
3SBio19.69B
Innovent Biologics14.51B
Shanghai Henlius Biotech7.42B
Akeso3.40B
Shanghai Junshi Biosciences2.78B
InnoCare Pharma2.64B
Revenue Rankings

RemeGen News

More News